AMPE Ampio Pharmaceuticals Inc

Price (delayed)

$1.80

Market cap

$352.24M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.08

Enterprise value

$337.29M

Sector: Healthcare
Industry: Biotechnology

Highlights

The company's debt fell by 25% YoY and by 8% QoQ
The EPS rose by 11% since the previous quarter
The net income has declined by 11% year-on-year but it is up by 10% since the previous quarter
Ampio Pharmaceuticals's equity has decreased by 4.2% from the previous quarter

Key stats

What are the main financial stats of AMPE
Market
Shares outstanding
195.69M
Market cap
$352.24M
Enterprise value
$337.29M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
20.99
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$14.38M
EBITDA
-$13.21M
Free cash flow
-$14.47M
Per share
EPS
-$0.08
Free cash flow per share
-$0.07
Book value per share
$0.09
Revenue per share
$0
TBVPS
$0.11
Balance sheet
Total assets
$21.73M
Total liabilities
$4.95M
Debt
$851,000
Equity
$16.78M
Working capital
$15.96M
Liquidity
Debt to equity
0.05
Current ratio
10.72
Quick ratio
9.62
Net debt/EBITDA
1.13
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-79.9%
Return on equity
-112%
Return on invested capital
-279.7%
Return on capital employed
-71.6%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

AMPE stock price

How has the Ampio Pharmaceuticals stock price performed over time
Intraday
-4.26%
1 week
-6.74%
1 month
-1.1%
1 year
185.71%
YTD
13.21%
QTD
6.51%

Financial performance

How have Ampio Pharmaceuticals's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$13.63M
Net income
-$14.38M
Gross margin
N/A
Net margin
N/A
Ampio Pharmaceuticals's operating income has increased by 38% YoY and by 14% QoQ
The net income has declined by 11% year-on-year but it is up by 10% since the previous quarter

Growth

What is Ampio Pharmaceuticals's growth rate over time

Valuation

What is Ampio Pharmaceuticals stock price valuation
P/E
N/A
P/B
20.99
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS rose by 11% since the previous quarter
AMPE's price to book (P/B) is 22% more than its last 4 quarters average of 17.2
Ampio Pharmaceuticals's equity has decreased by 4.2% from the previous quarter

Efficiency

How efficient is Ampio Pharmaceuticals business performance
The ROE has increased by 49% year-on-year and by 36% since the previous quarter
The return on assets has increased by 26% since the previous quarter and by 8% year-on-year
Ampio Pharmaceuticals's return on invested capital has increased by 18% QoQ but it has decreased by 15% YoY

Dividends

What is AMPE's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMPE.

Financial health

How did Ampio Pharmaceuticals financials performed over time
The company's total assets has surged by 146% YoY but it fell by 5% QoQ
The company's total liabilities fell by 28% YoY and by 8% QoQ
The company's debt is 95% lower than its equity
AMPE's debt to equity has dropped by 91% year-on-year
The company's debt fell by 25% YoY and by 8% QoQ

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.